Email Us
View Reports

Sleep Disorder Market

Sleep Disorder Market Analysis - By Disorder (Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders), By Device, By Treatment, By Region – Global Industry Analysis Growth Size and Competitive Analysis Forecast Report 2026

  • ID : 93191223  |  
  • Published : Feb-2019  |  
  • Region : Global  |  
  • Pages : 115   |  
  • Publisher : Polaris Market Research

Sleep disorder is defined as a sleep problem, which is characterized by snoring, insomnia, depression, and sleeps apnea. Recently, in a study, it is found that the approximately more than 75% of Americans from the age of 25 to 59 suffer from sleep disorder in the U.S. Sleep disorder is basically characterized by the difficulty in falling asleep, daytime fatigue, lack of concentration, anxiety, and depression.

Sleep Disorder Market Size and Growth Rate:

Sleep Disorder Market size was valued USD 1.31 billion in 2017, and it is expected to reach a decent growth rate from the period of 2018 to 2026. 

Sleep Disorder Market Growth Drivers:

The sleep disorder market is primarily driven by the increasing number of individual population suffering from various mental disorders, and raising awareness for the treatment of sleep disorders in the coming years. Furthermore, the changing lifestyle of the people, and rising preference to the sedentary lifestyle to also support the market growth in the coming years. Additionally, changing the working culture, increasing geriatric population, and lack of quality sleep to also boost the market growth during the forecast period.

On the other side, increasing morbidity due to sleep disorder has increased the healthcare cost, and related side effects of the drugs, and increasing patent expiries that are used in treating sleep disorders which would impede the market growth during the forecast period. The treatment for include medication, better sleeping habits, and devices. Medicines such as, Hetlioz (tasimelteon) by Vanda Pharmaceuticals, Intermezzo (zolpidem tartrate sublingual tablet) by Transcept Pharmaceuticals, and Silenor (doxepin) by Somaxon Pharma are some of the FDA approved drugs that are observed to be beneficial during the treatment of sleep disorders.

Sleep Disorder Market Major Key Players are mentioned in this Report:

  • GlaxoSmithKline plc
  • Becton Dickson and Company
  • Cardinal Health
  • Natus Medical Incorporated
  • Takeda Pharmaceutical Company Limited
  • Koninklijke Philips N.V.
  • Teva Pharmaceutical Industries Ltd
  • 10 plus More Key Players

Sleep Disorder Market Detailed Segmentation:

Sleep Disorder Market - By Disorder:

  • Insomnia
  • Hypersomnia
  • Insufficient Sleep Syndrome
  • Narcolepsy
  • Sleep Apnea
  • Sleep Breathing Disorders
  • Circadian Rhythm Disorders
  • Parasomnia
  • Sleep Eating Disorder
  • Sleep Terror
  • REM Sleep Behavior Disorder
  • Others
  • Sleep Movement Disorders
  • Restless Leg Syndrome
  • Sleep Leg Cramps

Sleep Disorder Market - By Devices:

  • Sleep Apnea Devices
  • Sleep Laboratories
  • Mattresses & Pillows

Sleep Disorder Market - By Treatment :

  • Psychiatric Treatment
  • Behavioral Treatment
  • Cognitive Behavioral Therapy
  • Medication Therapy
  • Prescription Drugs
  • OTC Drugs
  • Herbal Drugs

Sleep Disorder Market Regional Existence:

The market for sleep disorder in North America generated the highest revenue in 2017 and is expected to be the leading region globally during the forecast period. High number of patient population suffering the sleeping disorders is the primary factor accounting for the highest market growth. According to the US Department of Health and Human Services reports, approximately 20% Americans are suffering from sleep disorder. Thus, increasing demand for early treatments along with increasing patient pool, and growing patient awareness for proper diagnosis methods are factors boosting the growth in North America.

The Asia Pacific is estimated to be the fastest growing region in terms of revenue. Growing awareness about sleep disorders and developing healthcare infrastructure are some of the factors that are projected to generate lucrative opportunities for the market in APAC.

Sleep Disorder Market - By Geographical Segmentation:

  • North America

    • U. S.
    • Canada

  • Europe

    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • China
    • India
    • Japan
    • Australia
    • Singapore
    • Korea
    • Rest of Asia-Pacific

  • Latin America

    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America

  • Middle East and Africa

    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Table of Contents

1. Overview and Scope

1.1. Research goal & scope

1.2. Research assumptions

1.3. Research Methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key take-away

1.5. Stakeholders

2. Executive Summary

2.1. Market Definition

2.2. Market Segmentation

3. Sleep Disorder Market Insights

3.1. Sleep Disorder – Industry snapshot

3.2. Sleep Disorder - Ecosystem analysis

3.3. Sleep Disorder Market Dynamics

3.3.1. Sleep Disorder – Market Forces

3.3.1.1. Sleep Disorder Market Driver Analysis

3.3.1.2. Sleep Disorder Market Restraint/Challenges analysis

3.3.1.3. Sleep Disorder Market Opportunity Analysis

3.4. Industry analysis - Porter's five force

3.4.1. Bargaining power of supplier

3.4.2. Bargaining power of buyer

3.4.3. Threat of substitute

3.4.4. Threat of new entrant

3.4.5. Degree of competition

3.5. Sleep Disorder Market PEST Analysis

3.6. Sleep Disorder Market Value Chain Analysis

3.7. Sleep Disorder Industry Trends

3.8. Competitive Ranking Analysis, 2017

4. Sleep Disorder Market Size and Forecast by Disorder, 2018-2026

4.1. Key Findings

4.2. Insomnia

4.3. Hypersomnia

4.3.1. Insufficient Sleep Syndrome

4.3.2. Narcolepsy

4.4. Sleep Apnea

4.5. Sleep Breathing Disorders

4.6. Circadian Rhythm Disorders

4.7. Parasomnia

4.7.1. Sleep Eating Disorder

4.7.2. Sleep Terror

4.7.3. REM Sleep Behavior Disorder

4.8. Sleep Movement Disorders

4.8.1. Restless Leg Syndrome

4.8.2. Sleep Leg Cramps

5. Sleep Disorder Market Size and Forecast by Device, 2018-2026

5.1. Key Findings

5.2. Sleep Apnea Devices

5.3. Sleep Laboratories

5.4. Mattresses & Pillows

6. Sleep Disorder Market Size and Forecast by Treatment, 2018-2026

6.1. Key Findings

6.2. Psychiatric Treatment

6.3. Behavioral Treatment

6.4. Cognitive Behavioral Therapy

6.5. Medication Therapy

6.5.1. Prescription Drugs

6.5.2. OTC Drugs

6.5.3. Herbal Drugs

7. Sleep Disorder Market Size and Forecast by Region, 2018-2026

7.1. Key Findings

7.2. North America

7.2.1. U.S.

7.2.2. Canada

7.3. Europe

7.3.1. Germany

7.3.2. UK

7.3.3. France

7.3.4. Italy

7.3.5. Spain

7.3.6. Belgium

7.3.7. Russia

7.3.8. Netherlands

7.3.9. Rest of Europe

7.4. Asia-Pacific

7.4.1. China

7.4.2. India

7.4.3. Japan

7.4.4. Korea

7.4.5. Singapore

7.4.6. Malaysia

7.4.7. Indonesia

7.4.8. Thailand

7.4.9. Philippines

7.4.10. Rest of Asia-Pacific

7.5. Latin America

7.5.1. Brazil

7.5.2. Mexico

7.5.3. Argentina

7.5.4. Rest of LATAM

7.6. Middle East & Africa

7.6.1. UAE

7.6.2. Saudi Arabia

7.6.3. South Africa

7.6.4. Rest of MEA

8. Company Profiles

8.1. GlaxoSmithKline Plc

8.1.1. Overview

8.1.2. Financials

8.1.3. Product Benchmarking

8.1.4. Recent Developments

8.2. Becton Dickson and Company

8.2.1. Overview

8.2.2. Financials

8.2.3. Product Benchmarking

8.2.4. Recent Developments

8.3. Cardinal Health

8.3.1. Overview

8.3.2. Financials

8.3.3. Product Benchmarking

8.3.4. Recent Developments

8.4. Natus Medical Incorporated.

8.4.1. Overview

8.4.2. Financials

8.4.3. Product Benchmarking

8.4.4. Recent Developments

8.5. Takeda Pharmaceutical Company Limited

8.5.1. Overview

8.5.2. Financials

8.5.3. Product Benchmarking

8.5.4. Recent Developments

8.6. Koninklijke Philips N.V.

8.6.1. Overview

8.6.2. Financials

8.6.3. Product Benchmarking

8.6.4. Recent Developments

8.7. Teva Pharmaceutical Industries Ltd.

8.7.1. Overview

8.7.2. Financials

8.7.3. Product Benchmarking

8.7.4. Recent Developments

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?